Rekombinanter IL-6R (Tocilizumab Biosimilar) Antikörper
Research Grade
Reaktivität: Human
ELISA
Wirt: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target Alle IL-6R (Tocilizumab Biosimilar) Produkte
- IL-6R (Tocilizumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Mammalian Cells
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IL-6R (Tocilizumab Biosimilar) Antikörper ist unkonjugiert
-
Applikation
- ELISA
- Verwendungszweck
- Tocilizumab Biosimilar - Anti-IL-6R mAb
- Produktmerkmale
- Antibody Type: IgG1Kappa
- Güteklasse
- Research Grade
- Isotyp
- IgG1 kappa
-
anti-IL-6R (Tocilizumab Biosimilar) antibody
Reaktivität: Human ELISA, InhA Wirt: Kaninchen Monoclonal RhPM-1 unconjugated Recombinant Antibody
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS pH 7.5
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- 4°C for short term, -20°C for long term
-
- Target
- IL-6R (Tocilizumab Biosimilar)
- Abstract
- IL-6R (Tocilizumab Biosimilar) Produkte
- Synonyme
- CD126 antikoerper, IL-6R-1 antikoerper, IL-6RA antikoerper, IL6Q antikoerper, IL6RA antikoerper, IL6RQ antikoerper, gp80 antikoerper, interleukin 6 receptor antikoerper, IL6R antikoerper
- Substanzklasse
- Biosimilar
- Hintergrund
-
Tocilizumab
Tocilizumab, also known as atlizumab, is a recombinant humanized, anti-human monoclonal antibody (mAb) of the immunoglobulin G1κ subclass directed against soluble and membrane-bound interleukin-6 (IL-6) receptor (IL-6R) which plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer. - CAS-Nummer
- 375823-41-9
-
Sie sind hier:
